相关实验视频

Updated: Jan 15, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

获得和选择:在多发性髓瘤T细胞重定向疗法期间跟踪抗原逃逸

Joseph Kauer¹, Niels Weinhold¹, Marc S Raab¹

¹Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty, Heidelberg University, Heidelberg, Germany.

Blood cancer discovery

|October 13, 2025

概括

免疫治疗期间的基因组抗原逃逸可以使用化疗诱导的突变特征来追踪. 这些突变是在治疗期间获得的,而不是在患有血液癌症的患者中预先存在的.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫治疗是一种免疫疗法.

背景情况:

针对BCMA和GPRC5D的免疫疗法在治疗血液癌症方面表现有前途.
基因组抗原逃逸是治疗耐药性的潜在机制.
监测抗原逃逸需要强大的方法.

研究的目的:

开发和实施一个监测基因组抗原逃逸的时间工作流.
调查免疫疗法期间与抗原逃逸相关的突变的起源.

主要方法:

利用时间工作流来追踪基因组变化.
用化疗诱导的突变特征作为分子条形码.
分析了接受BCMA或GPRC5D导向免疫治疗的患者的基因组数据.

主要成果:

证明了在免疫疗法期间获得突变.
提供了这些突变在治疗期间出现的证据.
从先前存在的突变中获得了独特的治疗突变.

结论:

化疗诱导的突变特征作为有效的条形码来追踪抗原逃逸.
赋予抗原逃逸的基因组突变是在BCMA或GPRC5D导向免疫治疗期间获得的.
这种时间监测方法有助于理解血液癌症治疗中的抵抗机制.

更多相关视频

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...